Wellcome Trust-funded stem cell research has produced red blood cells fit for transfusion into humans, paving the way for the mass production of blood
It is the stuff of gothic science fiction: men in white coats in factories of blood and bones.
But the production of blood on an industrial scale could become a reality once a trial is conducted in which artificial blood made from human stem cells is tested in patients for the first time.
It is the latest breakthrough in scientists’ efforts to re-engineer the body, which have already resulted in the likes of 3d-printed bones and bionic limbs.
Marc Turner, the principal researcher in the £5 million programme funded by the Wellcome Trust, told The Telegraph that his team had made red blood cells fit for clinical transfusion.
Prof Turner has devised a technique to culture red blood cells from induced pluripotent stem (iPS) cells – cells that have been taken from humans and ‘rewound’ into stem cells. Biochemical conditions similar to those in the human body are then recreated to induce the iPS cells to mature into red blood cells – of the rare universal blood type O-.
“Although similar research has been conducted elsewhere, this is the first time anybody has manufactured blood to the appropriate quality and safety standards for transfusion into a human being,” said Prof Turner.
There are plans in place for the trial to be concluded by late 2016 or early 2017, he said. It will most likely involve the treatment of three patients with Thalassaemia, a blood disorder requiring regular transfusions. The behaviour of the manufactured blood cells will then be monitored.
“The cells will be safe,” he said, adding that there are processes whereby cells can be removed.
The technique highlights the prospect of a limitless supply of manufactured type O- blood, free of disease and compatible with all patients.
The Latest on: Artificial blood
via Google News
The Latest on: Artificial blood
- UK Launch for Most Advanced 'Artificial Pancreas', MiniMed 780Gon January 27, 2021 at 8:55 am
The MiniMed 780G system (Medtronic) advanced hybrid closed-loop insulin delivery system aimed at simplifying the management of type 1 diabetes is now available in the UK for people aged 7 to 80 years.
- AI-powered prostate cancer screening is 99% accurate with no probing or blood teston January 27, 2021 at 6:51 am
A new artificial intelligence-powered method to detect prostate cancer, taking just 20 minutes and appearing to be 99 per cent accurate, has been developed by scientists in South Korea. While the ...
- Individualized cancer therapy soon to be faster and more effective thanks to artificial intelligenceon January 27, 2021 at 5:21 am
Individualized cancer therapy soon to ... The treatment of cancer with new, individualized cell therapies is usually very costly and lengthy. Before treatment can take place, patients often have to ...
- At 7% CAGR, Global Artificial Blood Vessels Market Report 2020 Will Reach USD 3,300 Million By 2026: Says Facts & Factorson January 25, 2021 at 4:27 am
According to the research study, the global Artificial Blood Vessels Market was estimated at USD 2,100 Million in 2019 and is expected to reach USD 3,300 Million by 2026. The global Artificial Blood ...
- This artificial heart could help keep people on transplant waiting lists aliveon January 22, 2021 at 1:32 pm
A French company called Carmat has created an artificial heart that could potentially save the lives of people with end-stage biventricular heart failure.
- Artificial Blood Market 2021 | Size, Share, Demand, Trends and Analysis Research Report 2024on January 22, 2021 at 11:26 am
Jan (AmericaNewsHour) -- Global Artificial Blood Market is estimated to reach $10.73 billion by 2025; growing at a CAGR of 20.3% from 2017 to ...
- Artificial Blood Market Analysis with Key Players, Applications, Trends and Forecasts to 2025on January 22, 2021 at 5:39 am
Jan (Market Insight Reports) -- Selbyville, Delaware, The next five years the Artificial Blood market will register a 12.1% CAGR in terms ...
- This Artificial Heart Will Soon Be on the Market in Europeon January 20, 2021 at 7:00 am
Embedded electronics, microprocessors, and sensors regulate responses to the patient’s activity and adjust blood flow accordingly.
- Artificial Blood Vessel Market Fact-Based Analysis Focusing On SWOT Survey(2022-2031)on January 20, 2021 at 6:39 am
According to new reliable research on Artificial Blood Vessel Market (2022-2031), featuring a short universal view of the size of the market, geographical scope and key trends based on volume and ...
- New method uses artificial intelligence to map intestinal bacteria using feceson January 14, 2021 at 9:37 pm
The intestines and their bacteria are sometimes called our ’second brain’, but studying these bacteria in their natural environment is difficult. Now researchers from the University of Copenhagen have ...
via Bing News